Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Martin

Showing results (51-60 of 226) with videos related to

Pageof 23
Sort By:
Journal of Clinical Pharmacy and Therapeutics|October 1, 1996
Non-pharmacological modification of cardiac risk factors: Part 1C J Eagles, R Gulati, U Martin
Revista Clinica Espanola|April 15, 1976
[Pharmacological action of a new benzimidazole derivative. II. Protection against bacterial invasion]C Fernández, U Martin-Escudero, M Izquierdo
Journal of Clinical Pharmacy and Therapeutics|September 17, 2005
Use of moxonidine in elderly patients with resistant hypertensionU Martin, C Hill, D O' Mahony
FEBS Letters|January 11, 2001
The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1betaC Kollewe, D Neumann, M U Martin
Global Change Biology|May 20, 2014
A method for calculating a land-use change carbon footprint (LUC-CFP) for agricultural commodities - applications to Brazilian beef and soy, Indonesian palm oilU Martin Persson, Sabine Henders, Christel Cederberg
Lancet (London, England)|June 26, 2019
Healthy diets and sustainable food systemsRasmus Einarsson, Gavin McCrory, U Martin Persson
Frontiers in Psychology|July 6, 2016
An Eye on Animacy and IntentionDorothea U Martin, Conrad Perry, Jordy H Kaufman
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antioxidant therapy for the prevention of cardiovascular diseaseS L Nuttall, M J Kendall, U Martin
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery diseaseM J Kendall, S L Nuttall, U Martin
Nature Immunology|August 21, 2019
One hits (almost) allDiana Boraschi, Ron N Apte, Michael U Martin
Pageof 23

Showing results (51-60 of 226) with videos related to

Sort By:
Pageof 23
Journal of Clinical Pharmacy and Therapeutics|October 1, 1996
Non-pharmacological modification of cardiac risk factors: Part 1C J Eagles, R Gulati, U Martin
Revista Clinica Espanola|April 15, 1976
[Pharmacological action of a new benzimidazole derivative. II. Protection against bacterial invasion]C Fernández, U Martin-Escudero, M Izquierdo
Journal of Clinical Pharmacy and Therapeutics|September 17, 2005
Use of moxonidine in elderly patients with resistant hypertensionU Martin, C Hill, D O' Mahony
FEBS Letters|January 11, 2001
The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1betaC Kollewe, D Neumann, M U Martin
Global Change Biology|May 20, 2014
A method for calculating a land-use change carbon footprint (LUC-CFP) for agricultural commodities - applications to Brazilian beef and soy, Indonesian palm oilU Martin Persson, Sabine Henders, Christel Cederberg
Lancet (London, England)|June 26, 2019
Healthy diets and sustainable food systemsRasmus Einarsson, Gavin McCrory, U Martin Persson
Frontiers in Psychology|July 6, 2016
An Eye on Animacy and IntentionDorothea U Martin, Conrad Perry, Jordy H Kaufman
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antioxidant therapy for the prevention of cardiovascular diseaseS L Nuttall, M J Kendall, U Martin
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery diseaseM J Kendall, S L Nuttall, U Martin
Nature Immunology|August 21, 2019
One hits (almost) allDiana Boraschi, Ron N Apte, Michael U Martin
Pageof 23